Oncogenic IRFs Provide a Survival Advantage for EBV- or HTLV1- Transformed Cells through Induction of BIC Expression

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - 2012
Event15th International Symposium on EBV and Associated Diseases - Philadelphia
Duration: Jan 1 2012 → …

Conference

Conference15th International Symposium on EBV and Associated Diseases
Period1/1/12 → …

Disciplines

  • Internal Medicine

Cite this